2023 World Conference on Lung Cancer (Posters)-EP17.04. Lung Cancer Care in Singapore: A review of the Healthcare Registry, 2013-2020

EP17.04. Lung Cancer Care in Singapore: A review of the Healthcare Registry, 2013-2020 - PDF(Abstract)

Pdf Summary

This study reviewed lung cancer care in Singapore using data from the Healthcare Registry from 2013-2020. The research aimed to examine trends, the effect of diagnostic testing on drug use, and overall survival at an academic university-based cancer center. The study identified 2,192 lung cancer patients, with the majority being males aged 65-74 and having a history of smoking. Among patients with non-small cell lung cancer (NSCLC), 87% had non-squamous NSCLC. Metastatic disease was present at diagnosis for the majority of cases. In patients with advanced stage disease, testing rates for EGFR mutations, ALK gene rearrangement, and PD-L1 expression were high. Thirty-four percent of stage 4 NSCLC patients received first-line targeted therapy, and there was an increasing trend in the use of immunotherapy. One-year overall survival for stage IV NSCLC improved from 47% to 69%. The study concluded that rates of testing remained high, use of targeted therapy was consistent, and the role of immunotherapy expanded in line with global trends. The positive impact on overall survival was encouraging. However, there is a need to detect lung cancer at an earlier stage to improve median overall survival.

Asset Subtitle

Jia Li Low

Meta Tag

Speaker Jia Li Low

Topic Global Health, Health Services & Health Economics: Real World Data

Keywords

lung cancer

Singapore

diagnostic testing

overall survival

NSCLC

metastatic disease

targeted therapy

immunotherapy

testing rates

improve median overall survival